President Trump has promoted his efforts to lower drug prices. Many voters have yet to see relief from rising prescription and insurance costs.
The administration points to policies aimed at cutting medication expenses. Those measures have not reached every household facing higher bills.
For some voters, monthly prescription costs remain unchanged. Insurance premiums continue to climb, adding pressure to household budgets.
The gap between announced savings and real-world costs is drawing attention. Affordability remains a central concern for voters ahead of the midterms.
Campaign promises often differ from what consumers experience at the pharmacy counter. That disconnect may shape how people cast their ballots.
Economists note that drug pricing involves manufacturers, insurers, and middlemen. Changes to one part of the system do not guarantee lower prices for patients.
Voters are weighing these economic pressures against other issues. Whether drug price promises translate into savings could influence their decisions.
